Bristol Myers Squibb PE Ratio 2010-2022 | BMY

Current and historical p/e ratio for Bristol Myers Squibb (BMY) from 2010 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bristol Myers Squibb PE ratio as of May 17, 2022 is 9.82.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Bristol Myers Squibb PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2022-05-17 78.22 27.74
2022-03-31 73.03 $2.82 25.90
2021-12-31 61.35 $3.12 19.66
2021-09-30 58.22 $-2.40 0.00
2021-06-30 64.74 $-2.27 0.00
2021-03-31 61.16 $-2.78 0.00
2020-12-31 59.63 $-4.01 0.00
2020-09-30 57.08 $-0.11 0.00
2020-06-30 55.24 $-0.10 0.00
2020-03-31 51.95 $0.81 64.13
2019-12-31 59.40 $2.19 27.12
2019-09-30 46.54 $3.47 13.41
2019-06-30 41.26 $3.80 10.86
2019-03-31 43.03 $3.16 13.62
2018-12-31 46.46 $3.03 15.33
2018-09-30 55.13 $0.88 62.65
2018-06-30 48.79 $0.23 212.15
2018-03-31 55.41 $0.56 98.95
2017-12-31 53.34 $0.59 90.41
2017-09-30 55.15 $2.54 21.71
2017-06-30 47.88 $2.75 17.41
2017-03-31 46.38 $2.88 16.11
2016-12-31 49.52 $2.65 18.69
2016-09-30 45.38 $2.04 22.24
2016-06-30 61.89 $1.74 35.57
2016-03-31 53.48 $0.97 55.13
2015-12-31 57.25 $0.97 59.02
2015-09-30 49.00 $1.06 46.22
2015-06-30 54.43 $1.07 50.87
2015-03-31 52.46 $1.35 38.86
2014-12-31 48.01 $1.20 40.01
2014-09-30 41.08 $1.63 25.20
2014-06-30 38.64 $1.62 23.85
2014-03-31 41.10 $1.74 23.62
2013-12-31 42.05 $1.55 27.13
2013-09-30 36.10 $1.67 21.61
2013-06-30 34.58 $0.82 42.17
2013-03-31 31.60 $0.88 35.91
2012-12-31 24.74 $1.15 21.51
2012-09-30 25.36 $1.09 23.27
2012-06-30 26.76 $2.08 12.86
2012-03-31 24.87 $2.22 11.20
2011-12-31 25.71 $2.15 11.96
2011-09-30 22.67 $1.93 11.74
2011-06-30 20.92 $1.92 10.89
2011-03-31 18.87 $1.93 9.78
2010-12-31 18.44 $1.79 10.30
2010-09-30 18.88 $5.57 3.39
2010-06-30 17.17 $5.50 3.12
2010-03-31 18.15 $5.46 3.32
2009-12-31 16.96 $5.35 3.17
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $161.383B $46.385B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Stock Name Country Market Cap PE Ratio
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.475B 16.53
Biohaven Pharmaceutical Holding (BHVN) United States $9.944B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.681B 0.00
Emergent Biosolutions (EBS) United States $1.444B 6.18
Arcus Biosciences (RCUS) United States $1.389B 35.22
Myovant Sciences (MYOV) United Kingdom $0.879B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.509B 0.00
Gelesis Holdings (GLS) United States $0.362B 0.00
Zymeworks (ZYME) Canada $0.321B 0.00
Ambrx Biopharma (AMAM) United States $0.159B 0.00
Enzo Biochem (ENZ) United States $0.114B 23.50
SQZ Biotechnologies (SQZ) United States $0.093B 0.00